.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,731,374

« Back to Dashboard

Details for Patent: 4,731,374

Title: Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals
Abstract:This invention relates to new tetrahydrobenzthiazoles of general formula ##STR1## wherein R.sub.1 represents a hydrogen atom, an alkyl group, an alkenyl or alkynylk group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the above mentioned phenyl nuclei may each be substituted by 1 or 2 halogen atoms, R.sub.2 represents a hydrogen atom or an alkyl group, R.sub.3 represents a hydrogen atom, an alkyl group a cycloalkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the phenyl nucleus may be substituted by flurorine, chlorine or bromine atoms, R.sub.4 represents a hydrogen atom, an alkyl group, an alkyl or alkenyl group, or R.sub.3 and R.sub.4 together with the nitrogen atom between them represent a pyrrolidino, piperidino, hexamethyleneimino or morpholino group, the enantiomers and the acid addition salts thereof. The compounds of general formula I above in which one of the groups R.sub.1 or R.sub.3 or both groups R.sub.1 and R.sub.3 represent an acyl group are valuable intermediate products for preparing the other compounds of general formula I which have valuable pharmacological properties. The new compounds may be prepared using methods known per se.
Inventor(s): Griss, deceased; Gerhart (late of Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Kobinger; Walter (Vienna, AT), Pichler; Ludwig (Vienna, AT), Bauer; Rudolf (Wiesbaden, DE), Mierau; Joachim (Mainz, DE), Hinzen; Dieter (Zornheim, DE), Schingnitz; Gunter (Kreuznach, DE)
Assignee: Dr. Karl Thomae GmbH (Biberach an der Riss, DE)
Filing Date:Dec 19, 1985
Application Number:06/810,947
Claims:1. A tetrahydro-benzthiazole of the formula: ##STR15## wherein R.sub.1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl or alkynyl group each having 3 to 6 carbon atoms, an alkanoyl group having 1 to 6 carbon atoms, a phenyl alkyl or phenyl alkanoyl group having 1 to 3 carbon atoms in the alkyl part, wherein the above mentioned phenyl nuclei may be substituted by 1 or 2 halogen atoms;

R.sub.2 is a hydrogen atom or an alkyl group with 1 to 4 carbon atoms; and

R.sub.3 and R.sub.4 together with the nitrogen atom between them form a pyrrolidino group; or,

a pharmaceutically acceptable acid addition salt thereof.

2. A tetrahydro-benzthiazole of formula I, as claimed in claim 1, wherein the ##STR16## group is in the 5 or 6-position.

3. A tetrahydro-benzthiazole of the formula: ##STR17## wherein R.sub.1 is a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, an allyl, benzyl, 2-chloro-benzyl, 4-chloro-benzyl, 3,4-dichloro-benzyl or phenylethyl group;

R.sub.2 is a hydrogen atom, a methyl or ethyl group; and

R.sub.3 and R.sub.4 together with the nitrogen atom between them form a pyrrolidino group, wherein said pyrrolidino group is in the 5- or 6-position; or,

a pharmaceutically acceptable acid addition salt thereof.

4. A tetrahydro-benzthiazole of formula Ia, as claimed in claim 3, wherein the ##STR18## group is in the 6-position.

5. A tetrahydro-benzthiazole of the formula: ##STR19## wherein R.sub.1 and R.sub.2 together with the nitrogen atom between them form an amino or allylamino group; and,

R.sub.3 and R.sub.4 together with the nitrogen atom between them form a pyrrolidino group.

6. 2-amino-6-pyrrolidino-4,5,6,7-tetrahydro-benzthiazole, or a pharmaceutically acceptable acid addition salt thereof.

7. A pharmaceutical composition for treating parkinsonism or Parkinson's Disease comprising a therapeutically effective amount of a compound of claims 3, 4, 5 or 6 and a pharmaceutically acceptable carrier.

8. A method of treating parkinsonism which comprises administering to a host suffering from same a therapeutically effective amount of a compound of claims 3, 4, 5 or 6.

9. A method of treating Parkinson's disease which comprises administering to a host suffering from same a therapeutically effective amount of a compound of claims 3, 4, 5 or 6.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc